Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.
Bhasin
Shalender
S
Division of Endocrinology, Metabolism, and Molecular Medicine, UCLA-Charles R. Drew University of Medicine and Science, Los Angeles, California 90059, USA. sbhasin@ucla.edu
Singh
Atam B
AB
Mac
Ricky Phong
RP
Carter
Ballentine
B
Lee
Martin I
MI
Cunningham
Glenn R
GR
D000328:Adult; D000368:Aged; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011469:Prostatic Diseases / Q000209:etiology*; D012307:Risk Factors; D013739:Testosterone / Q000627:therapeutic use*
D013739:Testosterone; D017430:Prostate-Specific Antigen